AI has acquired a 1 million-square-foot facility in Southwest Memphis, which is expected to help in the planned expansion of its supercomputer.
Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...
The Stateline North development is made up of three sites at 5408, 5414, and 5420 Tulane Road near the border with ...
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $1,100.00. The company’s shares closed yesterday at $911.06.
Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...
Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...
Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...
Eli Lilly and Company (NYSE:LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription,... ByInvesting ...
NASHVILLE, Tenn. (WKRN) — The Distilled Spirits Council of the United States applauded President Donald Trump’s decision to suspend tariffs one day after some Canadian provinces started ...
It is tailored to patients being treated with Lilly's oncology drugs – which include ... pathway for the category with no patient co-pays. There are already more than 30 DiGAs that have approved ...
In a recent transaction, Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co (NYSE:LLY), sold a substantial portion of its holdings. According to a Form 4 filing... ByInvesting.com ...
© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...